Correlation Between Biofil Chemicals and EverQuote

Can any of the company-specific risk be diversified away by investing in both Biofil Chemicals and EverQuote at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofil Chemicals and EverQuote into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biofil Chemicals Pharmaceuticals and EverQuote Class A, you can compare the effects of market volatilities on Biofil Chemicals and EverQuote and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofil Chemicals with a short position of EverQuote. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofil Chemicals and EverQuote.

Diversification Opportunities for Biofil Chemicals and EverQuote

0.08

Correlation Coefficient

Biofil Chemicals  EverQuote

Significant diversification

The 3 months correlation between Biofil and EverQuote is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Biofil Chemicals Pharmaceutica and EverQuote Class A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EverQuote Class A and Biofil Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofil Chemicals Pharmaceuticals are associated (or correlated) with EverQuote. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EverQuote Class A has no effect on the direction of Biofil Chemicals i.e., Biofil Chemicals and EverQuote go up and down completely randomly.

Pair Corralation between Biofil Chemicals and EverQuote

Assuming the 90 days trading horizon Biofil Chemicals is expected to generate 22.55 times less return on investment than EverQuote. But when comparing it to its historical volatility, Biofil Chemicals Pharmaceuticals is 1.02 times less risky than EverQuote. It trades about 0.01 of its potential returns per unit of risk. EverQuote Class A is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  1,878  in EverQuote Class A on February 4, 2024 and sell it today you would earn a total of  297.00  from holding EverQuote Class A or generate 15.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	86.36%
Values	Daily Returns

Biofil Chemicals Pharmaceutica  vs.  EverQuote Class A

Biofil Chemicals Pha

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Biofil Chemicals Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound forward indicators, Biofil Chemicals is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

EverQuote Class A

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in EverQuote Class A are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating technical and fundamental indicators, EverQuote reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Biofil Chemicals and EverQuote

The main advantage of trading using opposite Biofil Chemicals and EverQuote positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofil Chemicals position performs unexpectedly, EverQuote can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EverQuote will offset losses from the drop in EverQuote's long position.

The idea behind Biofil Chemicals Pharmaceuticals and EverQuote Class A pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.